Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques

Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques

US Patent 8226994 · Granted Jul 24, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Powder solid compositions, process for their preparation, formulations and use t2025
Compositions comprising berberine2023
Compositions comprising berberine2023
Powder solid compositions, process for their preparation, formulations and use t2023
Compositions useful in the prevention and/or treatment of inflammation and pain2022
Diasteroselective process for the preparation of thiol- or disulfide-containing 2022
Powder solid dispersions comprising quercetin, process for their preparation and2022
Powder solid dispersions comprising quercetin, process for their preparation and2022
Extracts of Cynara cardunculus and Citrus aurantium bergamia, combinations there2022
Phaseolus vulgaris extracts, their use and formulations containing them2022
Process for the preparation of powder compositions2021
Use of isothiocyanate derivatives as modulators of peripheral and neuropathic pa2021